All patients who had undergone surgery for solitary BM between 2013 and 2019 at the authors’ neuro-oncological university center were entered into a computerized database. Patients with multiple BM and/or leptomeningeal involvement were excluded. The study was conducted in accordance with the Declaration of Helsinki, and the protocol was approved by the Ethics Committee of the University Hospital Bonn (No. 250/19). Informed consent was not sought as a retrospective study design was chosen.
Patient characteristics surveyed for further analysis consisted of radiological features, preoperative laboratory values, and BM location, as well as the location of the primary malignancy, the preoperative functional status of the affected patient, and the presence of other systemic metastases. In terms of location, two groups were established for further investigation on the basis of the supra- or infratentorial location of the BM. Infratentorial location was defined as within the cerebellum, and brainstem lesions were excluded from analysis. The functional status of patients undergoing surgery was assessed preoperatively according to the Karnofsky Performance Score (KPS) [8 (
link)]. The Charlson Comorbidity Index (CCI) was used to evaluate the comorbidity burden of patients prior to surgery as previously described [3 ]. During a weekly tumor board meeting, all the treatment strategies applied and further investigated were determined individually for each individual patient by interdisciplinary consensus and, if necessary, coordinated with the referring physicians and/or taken into account previous oncological therapies [9 (
link)]. In the present study, only patients with indication for surgical therapy were considered and further analyzed resulting in a consecutive cohort of patients with surgically treated BM. After BM resection, patients are transferred to their transferring hospital in order to conduct postoperative oncological treatment [10 (
link)].
To evaluate perioperative complication profiles in patients undergoing BM resection, a list of adverse events known as patient safety indicators (PSIs) and hospital-acquired conditions (HACs) was used as previously described [11 ]. These events were established by the Agency for Healthcare Research and Quality and the Center for Medicare and Medicaid Services. The PSIs included occurrences such as pressure ulcers, transfusion reactions, and postoperative hemorrhage, while HACs included screening for pneumonia, fall injuries, and catheter-associated urinary tract infections. Specific to cranial surgeries, complications such as cerebrospinal fluid leakage and postoperative seizures, were classified as cranial-surgery-related complications (CSCs) as previously described [12 (
link)]. Any intra- or postoperative adverse events that occurred within 30 days of the initial resection, with or without further surgical interventions, were considered perioperative complications.
Hamed M., Potthoff A.L., Heimann M., Schäfer N., Borger V., Radbruch A., Herrlinger U., Vatter H, & Schneider M. (2023). Survival in patients with surgically treated brain metastases: does infratentorial location matter?. Neurosurgical Review, 46(1), 80.